Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: A systematic review and meta-analysis

Current Medical Research and Opinion

Volumn 24, Issue 2, 2008, Pages 497-505

  Reynolds, Matthew W ^a   Shibata, Atsuko ^b   Zhao, Sean ^b   Jones, Natalie ^a   Fahrbach, Kyle ^a   Goodnough, Lawrence Tim ^c  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b AMGEN INC   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deep vein thrombosis; Epidemiology; Meta analysis; Pulmonary embolism; Thromboembolism

Indexed keywords

ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; LONGITUDINAL STUDY; LUNG EMBOLISM; MALIGNANT NEOPLASTIC DISEASE; MEDLINE; METHODOLOGY; POISSON DISTRIBUTION; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOLID TUMOR; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RESEARCH DESIGN; THROMBOEMBOLISM;

EID: 39749142166     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079908X261050     Document Type: Article

References (10)

1. Trousseau A. Phlegmasia alba dolens. Clinique Médicale de l'Hôtel-Dieu de Paris. Paris, France: JB Ballière et Fils, 1865:654-712
2. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-93
3. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160:809-15
4. Lee AYY. Epidemiology and management of venous thromboembolism in patients with cancer. Thromb Res 2003;110:167-72
5. Mandalà M, Ferretti G, Cremonesi M, et al. Venous thromboembolism and cancer: new issues for an old topic. Crit Rev Oncol Hematol 2003;48:65-80
6. Otten HM, Mathijssen J, ten Cate H, et al. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med 2004;164:190-4
7. Lee AYY, Levine M. The thrombophilic state induced by therapeutic agents in the cancer patient. Semin Thromb Hemost 1999;87:575-9
8. Cook DJ, Mulrow CD, Haynes RB, et al. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997;126:376-80
9. Alderson P, Green S, Higgins JPT, et al. Cochrane Collaboration Handbook 4.2.1 [updated December 2003]. In: The Cochrane Library. Chichester, UK, John Wiley, 2004
10. Nalysnyk L, Fahrbach K, Reynolds MW, et al. Adverse events in coronary artery bypass graft (CABG): a systematic review and analysis. Heart 2003;89;767-72